(Circulation. 2002;105:1420.)
© 2002 American Heart Association, Inc.
From the Departments of Cardiology (D.S., R.B., S.R., W.G.D., J.L.), Radiooncology (V.S., R.S.), and Medical Physics (R.M.), University of Erlangen-Nuremberg, Germany; and the Montreal Heart Institute (R.B.), Montreal, Canada.
Correspondence to Dr D. Scheinert, Medizinische KlinikKardiologie, Universität LeipzigHerzzentrum, Strümpellstr. 39, 04289 Leipzig, Germany. E-mail dierk.scheinert{at}gmx.de
| Abstract |
|---|
|
|
|---|
Methods and Results We analyzed the occurrence of postradiation coronary artery spasms in 1 animal study and 2 clinical trials investigating the effects of high-dose intracoronary ß-radiation after de novo coronary artery stenting. Irradiated segments (IRSs) proximal and distal to the stent were studied by quantitative coronary angiography after stenting, after radiation, and at the end of the procedure. There was an 67% overall incidence of coronary artery spasm in the IRSs immediately after ß-radiation compared with 9% after sham treatment (P<0.001). Whereas in most cases this phenomenon was only minor or moderate, in 12 cases, 4 (22%) animals and 8 (28%) patients, severe coronary spasm (>90% diameter stenosis) with significant ECG-changes or hemodynamic instability was observed. Relief of spasms was protracted (mean time until complete relief of spasm 423±122 seconds) and required repetitive intracoronary administration of nitroglycerin (mean dose: 1.2±0.6 mg).
Conclusions Vasoconstriction is a frequent reaction of coronary arteries after high-dose intracoronary ß-radiation, necessitating repetitive administration of vasodilators.
Key Words: stents restenosis radioisotopes vasoconstriction
| Introduction |
|---|
|
|
|---|
The present report details our observations regarding occurrence of coronary spasm in 3 different animal and clinical studies with high-dose intravascular ß-radiation after de novo coronary stenting.
| Methods |
|---|
|
|
|---|
Eighteen domestic juvenile swine were studied in the double balloon injury model.3 Animals were subjected to oversized balloon dilatation (Balloon to artery ratio 1.2 to 1.3 by online QCA) in the left anterior descending (n=8) or circumflex coronary artery (n=10).
Four weeks after balloon injury, stent implantation (stent diameter to artery ratio 1.2 to 1.3; stent length 13 mm) was performed followed by high-dose endovascular ß-radiation treatment. Animals underwent follow-up angiography 6 weeks after the procedure.
Nonrandomized Prospective Pilot Study
Fifteen patients were enrolled in a nonrandomized prospective registry with high-dose endovascular ß-irradiation after de novo coronary stenting. Patients with symptomatic type A and B1 stenoses, a reference vessel diameter of 3.0 to 3.5 mm, and a maximum lesion length of 15 mm were eligible for enrollment. Patients with acute myocardial infarction or troponine Ipositive unstable angina were excluded. Intravascular ultrasound (IVUS)guided direct stent implantation (ACS MultiLink RX Tristar; diameter 3.0 to 3.5 mm; length 18 mm) was performed followed by high-dose endovascular ß-radiation (Figure).
|
Randomized Prospective Study
The randomized phase of the study was designed to compare the efficacy of high-dose endovascular ß-radiation after IVUS-guided direct stenting with sham treatment. Exclusion and inclusion criteria and stent treatment protocol are similar to that used in the pilot study. After stenting, patients were randomized to radiation or sham treatment. In this report, we communicate the immediate results with 25 patients being enrolled.
Radiation Procedural Details
The medical ethics committee of our institution approved the investigational use of ß-radiation, and informed consent was obtained from all patients. Endovascular ß-irradiation or sham treatment was applied using the Beta-Cath system (Novoste Inc), which is a catheter based noncentered radiation delivery system described previously.4 The 40-mm radiation source train consists of a series of cylindrical seeds containing the radioisotope 90Sr/90Y sources and is bordered by 2 gold radiopaque markers. In all cases, IVUS was performed after stenting prior to radiation. By quantitative analysis of the motorized IVUS pull-back, the distances from the center of the catheter (representing the center of the radiation source) to the external elastic lamina were measured in the 4 major directions (every 90°) in multiple tomographic cross-sections throughout the stent and the adjacent vessel (cross-sections every 3 mm throughout the stent as well as 2 reference cross-sections proximal and distal to the stent, respectively). From these individual measurements, a mean reference radius was calculated. In all actively treated cases of the animal and the human studies, the effective dose of 24 Gy was applied at the depth of the calculated mean reference radius, which corresponds to an average dose of 28.7±0.7 Gy (range 21.7 to 35.8 Gy) at 2 mm from the center of the radiation source. For sham treatment an inactive, placebo source was delivered through the Beta-Cath system.
Angiographic Analysis
For the present report, the coronary angiograms after stent implantation, immediately after radiation, and at the end of the procedure were quantitatively assessed offline by an independent operator using the Quantcor software (Siemens, Erlangen, Germany). Nitroglycerin (0.3 mg) was given prior to all angiographic images. Minimal luminal diameter (MLD) and degree of stenosis (as a percentage of the diameter) were measured in the irradiated segments (IRSs) proximal and distal to the stent. The IRS was defined as the area encompassed by the 2 gold markers of the radiation source train.5 It was identified on angiography by contrast injection with the source in place.
Coronary artery spasms were quantified (using diameter stenosis) as severe (>90%), moderate (50% to 89%), mild (10% to 49%), or none (<10%).
Statistical Analysis
Data are expressed as counts and percentages, or mean±standard deviation. Continuous data measured before and after radiation treatment were compared using a 2-tailed paired Students t test. A value of P<0.05 was considered significant.
| Results |
|---|
|
|
|---|
In the animal study, coronary spasms were observed in 24 of 36 (67%) IRSs. Similarly, in the radiation treated patients of the pilot study and the treatment arm of the randomized trial, in total, 39 of 58 (67%) IRSs showed a severe or moderate vasoconstriction after brachytherapy. In contrast, only mild spasm was evident in 2 of 22 (9%) vessel segments undergoing sham treatment (Table 1). Clearly, the distal IRSs was more affected by major or moderate coronary spasm. Accordingly, postradiation MLD was significantly smaller in the distal IRSs as compared with the proximal IRSs (Table 2).
|
|
Clinically, significant ST-segment elevation occurred in 7 (24%) brachytherapy patients. Furthermore, 4 patients treated in the right coronary artery developed symptomatic bradycardia or atrioventricular block during radiation. Hemodynamic instability during or after radiation occurred in 3 cases (17%) from the animal study as well as in 4 radiation treated patients (14%). However, fractionation of radiation treatment became necessary in only 1 patient (3%).
In the human trials, all coronary spasms could be reversed by intracoronary administration of nitroglycerin (mean dose 1.2±0.6 mg; mean time until complete relief of spasm 423±22 seconds). All cases were completed successfully without in-hospital major adverse cardiac event. In the animal study, 2 animals with severe nitroglycerin refractory spasm died within 2 hours after the procedure due to stent thrombosis.
| Discussion |
|---|
|
|
|---|
According to animal experiments, irradiation can produce endothelial damage with severe impairment of vasomotoric function.69 Local administration of the vasodilator acetylcholine to irradiated coronary arteries induced vasoconstriction, with loss of smooth muscle response to nitroglycerin.6 Furthermore, isometric tension measurements of rat aortic rings in an organ bath showed an immediate increase in vascular tone, which reached a plateau about 5 minutes after the beginning of the radiation.7
In our clinical studies, an almost uniform vasoconstrictive response of the coronary artery after ß-irradiation was observed. However, considering the potential shielding effect after stenting, a very high dose was applied, which is over the upper limit of what has previously been used in large clinical trials where no or few cases with coronary spasms were reported. ST-segment analysis demonstrated similarly to the in vitro findings that in most cases the vasoconstriction developed during the first minutes of radiation and reached a maximum 4 to 6 minutes later. Intracoronary administration of nitroglycerin had insufficient effect; repetitive doses were necessary to achieve complete relief of spasm. These findings support a severe impairment of the endothelium-dependent smooth muscle cell relaxation induced by high-dose radiation.
Moreover, it has recently been reported that endovascular radiation contributes to a dose-dependent increase in platelet recruitment at the angioplasty site.8,9 The release of vasoconstrictive mediators from activated platelets may also be a mechanism that could contribute to the development of arterial spasm.
Clinically, the phenomenon of nitroglycerin-resistant coronary artery spasm may provoke mechanical attempts for treatment of this condition including balloon dilatation and stent implantation. In many cases, the additional trauma of these manipulations will extend beyond the effectively radiated area causing a so-called edge effect due to Geographic Miss (injury not covered by prescribed dose of radiation). Recently, Sabate et al5 demonstrated a Geographic Miss in 31.9% of the IRSs resulting in significantly higher restenosis rates as compared with uninjured but effectively radiated edges (40.9% versus 1.9%; P<0.001).
In summary, vasoconstriction is a frequent reaction of coronary arteries to high-dose intracoronary ß-irradiation with more than 28 Gy on average, which may be due to acute radiation-induced endothelial dysfunction and/or platelet adhesion. Recognition of this phenomenon is important and may result in improved interventional results, if vasoconstrictions are treated by preventive and repetitive administration of vasodilators rather than by additional mechanical interventions.
Received December 17, 2001; revision received January 28, 2002; accepted January 28, 2002.
| References |
|---|
|
|
|---|
-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med. 2001; 344: 250256.
-radiation on vascular arterial tone. Br J Pharmacol. 1998; 123: 11681172.[CrossRef][Medline]
[Order article via Infotrieve]This article has been cited by other articles:
![]() |
M. Togni and O. M. Hess Reply J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1912 - 1913. [Full Text] [PDF] |
||||
![]() |
P. Erne, P. Jamshidi, P. Juelke, H.-P. Hafner, P. Thum, and T. Resink Brachytherapy: Potential therapy for refractory coronary spasm J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1415 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Togni, S. Windecker, P. Wenaweser, D. Tueller, A. Kaisaier, W. Maier, B. Meier, and O. M. Hess Deleterious Effect of Coronary Brachytherapy on Vasomotor Response to Exercise Circulation, July 13, 2004; 110(2): 135 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. S. Kyriakides, I. Rassias, D. T. Kremastinos, D. Scheinert, R. Burckhard, S. Ropers, W.G. Daniel, J. Ludwig, V. Strnad, R. Sauer, et al. Intravascular {beta}-Radiation May Acutely Increase Coronary Collateral Blood Flow in Patients With Coronary Artery Disease * Response Circulation, January 28, 2003; 107 (3): e24 - e24. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |